$FNWD
Finward Bancorp

2020 Q1 Form 10-Q Financial Statement

#000143774920009522 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q1
Revenue $12.87M $12.49M
YoY Change 3.06% 42.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.050M -$480.0K $750.0K
YoY Change 40.0% -167.61% 11.94%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.198M $1.887M
YoY Change 16.48% 110.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.704M $2.430M $2.562M
YoY Change 44.57% -20.33% -13.91%
Income Tax $512.0K $160.0K $340.0K
% Of Pretax Income 13.82% 6.58% 13.27%
Net Earnings $3.113M $2.270M $2.222M
YoY Change 40.1% -14.02% -13.24%
Net Earnings / Revenue 24.19% 17.79%
Basic Earnings Per Share $0.92 $0.66
Diluted Earnings Per Share $0.92 $658.0K $0.66
COMMON SHARES
Basic Shares Outstanding 3.459M 3.452M 3.343M
Diluted Shares Outstanding 3.459M 3.343M

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $42.15M $47.26M $60.76M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $28.93M $29.41M $27.93M
YoY Change 3.56% 18.46% 43.98%
Goodwill $11.11M $11.11M $10.74M
YoY Change 3.4% 35.97%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.350B $1.329B $1.268B
YoY Change 6.43% 21.22% 35.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $17.40M $14.80M $10.80M
YoY Change 61.11% 43.69% 12.5%
Deferred Revenue
YoY Change
Short-Term Debt $13.00M $11.50M $12.70M
YoY Change 2.36% -0.86% -5.22%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.40M $14.80M $10.80M
YoY Change 61.11% 43.69% 12.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $14.00M $20.00M
YoY Change -100.0% -67.44% -34.21%
Other Long-Term Liabilities $3.300M
YoY Change
Total Long-Term Liabilities $3.300M $14.00M $20.00M
YoY Change -83.5% -67.44% -34.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.40M $14.80M $10.80M
Total Long-Term Liabilities $3.300M $14.00M $20.00M
Total Liabilities $1.209B $1.195B $1.145B
YoY Change 5.6% 20.1% 34.92%
SHAREHOLDERS EQUITY
Retained Earnings $102.3M $100.2M $93.52M
YoY Change 9.39% 8.5%
Common Stock $29.67M $29.66M $29.49M
YoY Change 0.6% 148.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $133.5M $133.5M $123.2M
YoY Change
Total Liabilities & Shareholders Equity $1.350B $1.329B $1.268B
YoY Change 6.43% 21.22% 35.15%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q1
OPERATING ACTIVITIES
Net Income $3.113M $2.270M $2.222M
YoY Change 40.1% -14.02% -13.24%
Depreciation, Depletion And Amortization $1.050M -$480.0K $750.0K
YoY Change 40.0% -167.61% 11.94%
Cash From Operating Activities $9.364M $90.00K $1.416M
YoY Change 561.3% -98.91% -52.34%
INVESTING ACTIVITIES
Capital Expenditures $200.0K -$920.0K $44.00K
YoY Change 354.55% 135.9% -81.28%
Acquisitions $15.38M
YoY Change
Other Investing Activities -$21.97M -$19.43M $37.46M
YoY Change -158.65% -4.85% -679.88%
Cash From Investing Activities -$22.17M -$20.36M $37.41M
YoY Change -159.26% -2.12% -658.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $7.694M -4.400M 4.795M
YoY Change 60.46% -127.99% -63.43%
NET CHANGE
Cash From Operating Activities $9.364M 90.00K 1.416M
Cash From Investing Activities -$22.17M -20.36M 37.41M
Cash From Financing Activities $7.694M -4.400M 4.795M
Net Change In Cash -$5.112M -24.67M 43.63M
YoY Change -111.72% -878.23% 364.59%
FREE CASH FLOW
Cash From Operating Activities $9.364M $90.00K $1.416M
Capital Expenditures $200.0K -$920.0K $44.00K
Free Cash Flow $9.164M $1.010M $1.372M
YoY Change 567.93% -88.31% -49.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000919864
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3463136
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
NORTHWEST INDIANA BANCORP
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Security12g Title
Security12gTitle
Common Stock, without par value
CY2020Q1 dei Trading Symbol
TradingSymbol
nwin
CY2020Q1 nwin Assets Management Income
AssetsManagementIncome
554000
CY2019Q1 nwin Assets Management Income
AssetsManagementIncome
500000
CY2020Q1 nwin Available For Sale Securities Debt Maturities After Five Through Ten Years Tax Equivalent Yield Rate
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsTaxEquivalentYieldRate
0.0439
CY2020Q1 nwin Available For Sale Securities Debt Maturities After One Through Five Years Tax Equivalent Yield Rate
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsTaxEquivalentYieldRate
0.0479
CY2020Q1 nwin Available For Sale Securities Debt Maturities After Ten Years Tax Equivalent Yield Rate
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsTaxEquivalentYieldRate
0.0393
CY2020Q1 nwin Available For Sale Securities Debt Maturities Within One Year Tax Equivalent Yield Rate
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearTaxEquivalentYieldRate
0.0617
CY2020Q1 nwin Available For Sale Securities Debt Without A Single Maturity Date Tax Equivalent Yield Rate
AvailableForSaleSecuritiesDebtWithoutASingleMaturityDateTaxEquivalentYieldRate
0.0225
CY2020Q1 nwin Available For Sale Securities Tax Equivalent Yield Rate
AvailableForSaleSecuritiesTaxEquivalentYieldRate
0.0317
CY2020Q1 nwin Fees And Commission Depositor Accounts
FeesAndCommissionDepositorAccounts
1049000
CY2019Q1 nwin Fees And Commission Depositor Accounts
FeesAndCommissionDepositorAccounts
1162000
CY2020Q1 nwin Financing Receivable Purchased Credit Impaired Individually Evaluated For Impairment
FinancingReceivablePurchasedCreditImpairedIndividuallyEvaluatedForImpairment
3937000
CY2019Q4 nwin Financing Receivable Purchased Credit Impaired Individually Evaluated For Impairment
FinancingReceivablePurchasedCreditImpairedIndividuallyEvaluatedForImpairment
4107000
CY2020Q1 nwin Financing Receivables Acquired Accretable Yield Collected Current Year
FinancingReceivablesAcquiredAccretableYieldCollectedCurrentYear
361000
CY2020Q1 nwin Financing Receivables Acquired Accretable Yield To Be Collected
FinancingReceivablesAcquiredAccretableYieldToBeCollected
3477000
CY2020Q1 nwin Financing Receivables Acquired Accretable Yield To Be Collected Remainder Of Fiscal Year
FinancingReceivablesAcquiredAccretableYieldToBeCollectedRemainderOfFiscalYear
866000
CY2020Q1 nwin Financing Receivables Acquired Accretable Yield To Be Collected Year Four
FinancingReceivablesAcquiredAccretableYieldToBeCollectedYearFour
395000
CY2020Q1 nwin Financing Receivables Acquired Accretable Yield To Be Collected Year Three
FinancingReceivablesAcquiredAccretableYieldToBeCollectedYearThree
1103000
CY2020Q1 nwin Financing Receivables Acquired Accretable Yield To Be Collected Year Two
FinancingReceivablesAcquiredAccretableYieldToBeCollectedYearTwo
1113000
CY2020Q1 nwin Financing Receivables Acquired Accretableyield Amount Collected Previous Year
FinancingReceivablesAcquiredAccretableyieldAmountCollectedPreviousYear
422000
CY2020Q1 nwin Finitelived Intangible Asset Expected Amortization Year Seven
FinitelivedIntangibleAssetExpectedAmortizationYearSeven
CY2020Q1 nwin Finitelived Intangible Asset Expected Amortization Year Six
FinitelivedIntangibleAssetExpectedAmortizationYearSix
261000
CY2020Q1 nwin Impaired Financing Receivable Fair Value
ImpairedFinancingReceivableFairValue
6800000
CY2019Q4 nwin Impaired Financing Receivable Fair Value
ImpairedFinancingReceivableFairValue
7100000
CY2020Q1 nwin Loans And Leases Receivable Loans In Process Increase Reduction
LoansAndLeasesReceivableLoansInProcessIncreaseReduction
-277000
CY2019Q4 nwin Loans And Leases Receivable Loans In Process Increase Reduction
LoansAndLeasesReceivableLoansInProcessIncreaseReduction
21000
CY2020Q1 nwin Net Surrender Value Of Restricted Stock Awards
NetSurrenderValueOfRestrictedStockAwards
85000
CY2019Q1 nwin Net Surrender Value Of Restricted Stock Awards
NetSurrenderValueOfRestrictedStockAwards
CY2020Q1 nwin Other Noninterest Income Excluding Bank Owned Life Insurance Income
OtherNoninterestIncomeExcludingBankOwnedLifeInsuranceIncome
569000
CY2019Q1 nwin Other Noninterest Income Excluding Bank Owned Life Insurance Income
OtherNoninterestIncomeExcludingBankOwnedLifeInsuranceIncome
124000
CY2020Q1 nwin Payments For Proceeds From Certificates Of Deposit In Other Financial Institutions
PaymentsForProceedsFromCertificatesOfDepositInOtherFinancialInstitutions
-429000
CY2019Q1 nwin Payments For Proceeds From Certificates Of Deposit In Other Financial Institutions
PaymentsForProceedsFromCertificatesOfDepositInOtherFinancialInstitutions
191000
CY2020Q1 nwin Share Based Compensation Expense Estimated For Remainder Of Fiscal Year
ShareBasedCompensationExpenseEstimatedForRemainderOfFiscalYear
322000
CY2020Q1 nwin Share Based Compensation Expense Estimated For Year Four
ShareBasedCompensationExpenseEstimatedForYearFour
32000
CY2020Q1 nwin Share Based Compensation Expense Estimated For Year Three
ShareBasedCompensationExpenseEstimatedForYearThree
209000
CY2020Q1 nwin Share Based Compensation Expense Estimated For Year Two
ShareBasedCompensationExpenseEstimatedForYearTwo
339000
CY2020Q1 nwin Share Based Compensation Expense Estimated Future Compensation Total
ShareBasedCompensationExpenseEstimatedFutureCompensationTotal
902000
CY2020Q1 nwin Transfers From Loans To Foreclosed Real Estate
TransfersFromLoansToForeclosedRealEstate
23000
CY2019Q1 nwin Transfers From Loans To Foreclosed Real Estate
TransfersFromLoansToForeclosedRealEstate
193000
CY2020Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
20639000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
14750000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4261000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8686000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29666000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29657000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
71000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
94000
CY2020Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6341000
CY2019Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-806000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
71000
CY2020Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
10000
CY2019Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
23000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
12000
CY2019Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
66000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
248000
CY2020Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
12000
CY2019Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
17000
CY2020Q1 us-gaap Assets
Assets
1349927000
CY2019Q4 us-gaap Assets
Assets
1328722000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12501000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6653000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1513000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1267000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
282399000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
271833000
CY2020Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2200000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1424000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1191000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1513000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1267000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
6831000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
29367000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
89000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
76000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
6058000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
13226000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
773000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
16141000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4554000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3122000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
109870000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
16903000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
158938000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
293387000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
277219000
CY2020Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
513000
CY2019Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
356000
CY2020Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
3000
CY2019Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
4000
CY2020Q1 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
5
CY2019Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
11
CY2020Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
7
CY2019Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
28
CY2020Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
2
CY2019Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
17
CY2020Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
30186000
CY2019Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
30017000
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: Arial; font-size: 10pt; margin: 0pt;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1</div> - Basis of Presentation</div></div> <div style=" font-family: Arial; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">The consolidated financial statements include the accounts of NorthWest Indiana Bancorp (the &#x201c;Bancorp&#x201d; or &#x201c;NWIN&#x201d;), its wholly-owned subsidiaries NWIN Risk Management, Inc. (a captive insurance subsidiary) and Peoples Bank SB (the &#x201c;Bank&#x201d;), and the Bank&#x2019;s wholly-owned subsidiaries, Peoples Service Corporation, NWIN, LLC, NWIN Funding, Incorporated, and Columbia Development Company, LLC. The Bancorp&#x2019;s business activities include being a holding company for the Bank as well as a holding company for NWIN Risk Management, Inc. The Bancorp&#x2019;s earnings are primarily dependent upon the earnings of the Bank. The accompanying unaudited consolidated financial statements were prepared in accordance with instructions for Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q and, therefore, do <div style="display: inline; font-style: italic; font: inherit;">not</div> include all disclosures required by U.S. generally accepted accounting principles for complete presentation of consolidated financial statements. In the opinion of management, the consolidated financial statements contain all adjustments necessary to present fairly the consolidated balance sheets of the Bancorp as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019, </div>and the consolidated statements of income, comprehensive income, changes in stockholders&#x2019; equity, and consolidated statements of cash flows for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019.</div> The income reported for the <div style="display: inline; font-style: italic; font: inherit;">three</div> month period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>is <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results to be expected for the full year.</div></div>
CY2019Q1 us-gaap Business Acquisition Share Price
BusinessAcquisitionSharePrice
42
CY2020Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2019Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
52560000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47258000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17139000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42146000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60764000
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5112000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
43625000
CY2020Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
26155000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
20964000
CY2020Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
42146000
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
47258000
CY2020Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
1741000
CY2019Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2170000
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.31
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.31
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2020Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3463136
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3451797
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3463136
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3451797
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7617000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5255000
CY2020Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
510000
CY2019Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
352000
CY2020Q1 us-gaap Deposits
Deposits
1161642000
CY2019Q4 us-gaap Deposits
Deposits
1154370000
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1039000
CY2019Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
731000
CY2020Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
CY2020Q1 us-gaap Derivative Assets
DerivativeAssets
3986000
CY2019Q4 us-gaap Derivative Assets
DerivativeAssets
1544000
CY2020Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
CY2020Q1 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
CY2020Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
3350000
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
2290000
CY2020Q1 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
CY2020Q1 us-gaap Derivative Fair Value Amount Offset Against Collateral Net
DerivativeFairValueAmountOffsetAgainstCollateralNet
3986000
CY2019Q4 us-gaap Derivative Fair Value Amount Offset Against Collateral Net
DerivativeFairValueAmountOffsetAgainstCollateralNet
1544000
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
3986000
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1544000
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
3282000
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1358000
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
68000
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
932000
CY2020Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
3986000
CY2019Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
1544000
CY2020Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain
518000
CY2019Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain
220000
CY2020Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
3282000
CY2019Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
1358000
CY2020Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
3282000
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1358000
CY2020Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
CY2019Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
CY2020Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: Arial; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">12</div> - Upcoming Accounting Standards</div>&nbsp;</div> <div style=" font-family: Arial; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">In <div style="display: inline; font-style: italic; font: inherit;"> June 2016, </div>FASB issued ASU <div style="display: inline; font-style: italic; font: inherit;">No.</div> <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13,</div> Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. The ASU includes increased disclosures and various changes to the accounting and measurement of financial assets including the Bancorp&#x2019;s loans and available-for-sale and held-to-maturity debt securities. Each financial asset presented on the balance sheet would have a unique allowance for credit losses valuation account that is deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected on the financial asset. The amendments in this ASU also eliminate the probable initial recognition threshold in current GAAP and instead, reflect an entity&#x2019;s current estimate of all expected credit losses using reasonable and supportable forecasts. In <div style="display: inline; font-style: italic; font: inherit;"> October 2019, </div>the FASB voted and approved proposed changes to the effective date of this ASU for smaller reporting companies, such as the Bancorp, and other non-SEC reporting entities. The approval changed the effective date of the ASU to fiscal years beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2022, </div>including interim periods within those fiscal periods. The new credit loss guidance will be effective for the Bancorp's year ending <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2023. </div>Upon adoption, the ASU will be applied using a modified retrospective transition method to the beginning of the <div style="display: inline; font-style: italic; font: inherit;">first</div> reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. Early adoption for all institutions is permitted for fiscal years beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2018, </div>including interim periods within those fiscal years. Management is in the process of evaluating the impact adoption of this update will have on the Bancorp&#x2019;s consolidated financial statements. This process of evaluation has engaged multiple areas of the Bancorp&#x2019;s management in discussing loss estimation methods and the application of these methods to specific segments of the loans receivable portfolio. Management has been actively monitoring developments and evaluating the use of different methods allowed. Due to continuing development of understanding of application, additional time is required to understand how this ASU will affect the Bancorp&#x2019;s financial statements. Management plans on running parallel calculations during the year and finalizing a method or methods of adoption in time for the effective date.</div></div>
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1035000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1074000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
919000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
962000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
983000
CY2020Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
CY2019Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
172925000
CY2020Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
196000
CY2019Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
91000
CY2020Q1 us-gaap Federal Funds Sold
FederalFundsSold
872000
CY2019Q4 us-gaap Federal Funds Sold
FederalFundsSold
15544000
CY2020Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
14000000
CY2019Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
14000000
CY2020Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3912000
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3912000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
9134000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
8833000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
377000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
166000
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
911811000
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
899651000
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
3214000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
3111000
CY2020Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1137000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
866000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
895582000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
892219000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
6938000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
6507000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
23380000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
14650000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
746000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
994000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
556000
CY2019Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
703000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
12869000
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
12487000
CY2020Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
1705000
CY2019Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
1801000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4865000
CY2020Q1 us-gaap Foreclosed Assets
ForeclosedAssets
1032000
CY2019Q4 us-gaap Foreclosed Assets
ForeclosedAssets
1083000
CY2020Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
635000
CY2019Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
242000
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
60000
CY2019Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
27000
CY2020Q1 us-gaap Goodwill
Goodwill
11109000
CY2019Q4 us-gaap Goodwill
Goodwill
11109000
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7200000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7200000
CY2020Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
377000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
166000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3704000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2562000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
512000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
340000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
85000
CY2019Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
430000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5885000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-964000
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
7272000
CY2019Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
27641000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1155000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
50000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases Held In Portfolio
InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio
11029000
CY2019Q1 us-gaap Interest And Fee Income Loans And Leases Held In Portfolio
InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio
10543000
CY2020Q1 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
1485000
CY2019Q1 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
1684000
CY2020Q1 us-gaap Interest And Fee Income Loans Consumer
InterestAndFeeIncomeLoansConsumer
187000
CY2019Q1 us-gaap Interest And Fee Income Loans Consumer
InterestAndFeeIncomeLoansConsumer
111000
CY2020Q1 us-gaap Interest And Fee Income Loans Real Estate Construction
InterestAndFeeIncomeLoansRealEstateConstruction
9357000
CY2019Q1 us-gaap Interest And Fee Income Loans Real Estate Construction
InterestAndFeeIncomeLoansRealEstateConstruction
8748000
CY2020Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
976423000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
982276000
CY2020Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
15119000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
10750000
CY2020Q1 us-gaap Interest Expense
InterestExpense
2198000
CY2019Q1 us-gaap Interest Expense
InterestExpense
1887000
CY2020Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
94000
CY2019Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
166000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10600000
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2064000
CY2019Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1672000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
10157000
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
10283000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10671000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
2283000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
1907000
CY2020Q1 us-gaap Interest Receivable
InterestReceivable
4114000
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
4029000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5217000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4676000
CY2020Q1 us-gaap Liabilities
Liabilities
1209272000
CY2019Q4 us-gaap Liabilities
Liabilities
1194619000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1349927000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1328722000
CY2020Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
CY2019Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
145546000
CY2020Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
169000
CY2019Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
163000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
9511000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
8999000
CY2018Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7962000
CY2019Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
8236000
CY2020Q1 us-gaap Loans And Leases Receivable Before Fees Gross
LoansAndLeasesReceivableBeforeFeesGross
915371000
CY2019Q4 us-gaap Loans And Leases Receivable Before Fees Gross
LoansAndLeasesReceivableBeforeFeesGross
903956000
CY2020Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
918962000
CY2019Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
906869000
CY2020Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
909451000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
897870000
CY2020Q1 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
5375000
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
6091000
CY2020Q1 us-gaap Marketing Expense
MarketingExpense
208000
CY2019Q1 us-gaap Marketing Expense
MarketingExpense
263000
CY2020Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
780397000
CY2019Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
771018000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7694000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4795000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22339000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
37414000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9533000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1416000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3192000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2222000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3192000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2222000
CY2020Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
CY2019Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
5491000
CY2020Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
185219000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
172094000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
9999000
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
10291000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
3546000
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
2570000
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
918962000
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
906869000
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
1409000
CY2019Q1 us-gaap Occupancy Net
OccupancyNet
1123000
CY2020Q1 us-gaap Other Assets
OtherAssets
18547000
CY2019Q4 us-gaap Other Assets
OtherAssets
18557000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
5602000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
3831000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4425000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3033000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
1177000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
798000
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
510000
CY2019Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
352000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
6112000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4183000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3033000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4425000
CY2020Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
135000
CY2019Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
143000
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2413000
CY2019Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3435000
CY2019 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses
0
CY2020Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment
CY2019Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
173000
CY2020Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
173000
CY2020Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
24870000
CY2019Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
9760000
CY2020Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
12118000
CY2019Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
12985000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1070000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
909000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
44972000
CY2019Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
21424000
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
15378000
CY2020Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
169000
CY2019Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
163000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
200000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44000
CY2020Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
CY2019Q1 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
CY2020Q1 us-gaap Proceeds From Loans
ProceedsFromLoans
26197000
CY2019Q1 us-gaap Proceeds From Loans
ProceedsFromLoans
9883000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
16671000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
5704000
CY2020Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
1492000
CY2019Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
1063000
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
17886000
CY2019Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
13518000
CY2020Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
134000
CY2019Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
439000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28927000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29407000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
514000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
317000
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
514000
CY2019Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
317000
CY2020Q1 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
CY2019Q1 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
23000000
CY2020Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
40000
CY2019Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
49000
CY2020Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
85000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
102303000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
100185000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
11499000
CY2020Q1 us-gaap Security Owned And Pledged As Collateral Fair Value
SecurityOwnedAndPledgedAsCollateralFairValue
54500000
CY2019Q4 us-gaap Security Owned And Pledged As Collateral Fair Value
SecurityOwnedAndPledgedAsCollateralFairValue
65500000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
94000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
71000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7407
CY2020Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
12991000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13243
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
43
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
44.30
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
27423
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
30205
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
37048
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
32.58
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
35.63
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
40.13
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
4625
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
6400
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
29.37
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
27.50
CY2020Q1 us-gaap Stock Issued1
StockIssued1
CY2019Q1 us-gaap Stock Issued1
StockIssued1
17492000
CY2019Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
416478
CY2020Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
1904
CY2019Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
17492000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
140655000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
134103000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
101464000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
123247000
CY2020Q1 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
3314000
CY2019Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
2934000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3458505
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3343183
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3458505
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3343183

Files In Submission

Name View Source Status
0001437749-20-009522-index-headers.html Edgar Link pending
0001437749-20-009522-index.html Edgar Link pending
0001437749-20-009522.txt Edgar Link pending
0001437749-20-009522-xbrl.zip Edgar Link pending
ex_183224.htm Edgar Link pending
ex_183225.htm Edgar Link pending
ex_183230.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nwin-20200331.xml Edgar Link completed
nwin-20200331.xsd Edgar Link pending
nwin-20200331_cal.xml Edgar Link unprocessable
nwin-20200331_def.xml Edgar Link unprocessable
nwin-20200331_lab.xml Edgar Link unprocessable
nwin-20200331_pre.xml Edgar Link unprocessable
nwin20200331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending